318 related articles for article (PubMed ID: 33490040)
1. Overview of Biologically Active Nucleoside Phosphonates.
Groaz E; De Jonghe S
Front Chem; 2020; 8():616863. PubMed ID: 33490040
[TBL] [Abstract][Full Text] [Related]
2. Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects.
Krečmerová M; Majer P; Rais R; Slusher BS
Front Chem; 2022; 10():889737. PubMed ID: 35668826
[TBL] [Abstract][Full Text] [Related]
3. Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy.
Pertusati F; Serpi M; McGuigan C
Antivir Chem Chemother; 2012 May; 22(5):181-203. PubMed ID: 22182785
[TBL] [Abstract][Full Text] [Related]
4. Medicinal chemistry of fluorinated cyclic and acyclic nucleoside phosphonates.
Baszczyňski O; Janeba Z
Med Res Rev; 2013 Nov; 33(6):1304-44. PubMed ID: 23893552
[TBL] [Abstract][Full Text] [Related]
5. Symmetrical diamidate prodrugs of nucleotide analogues for drug delivery.
Pertusati F; McGuigan C; Serpi M
Curr Protoc Nucleic Acid Chem; 2015 Mar; 60():15.6.1-15.6.10. PubMed ID: 25754890
[TBL] [Abstract][Full Text] [Related]
6. The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond.
De Clercq E
Biochem Pharmacol; 2011 Jul; 82(2):99-109. PubMed ID: 21501598
[TBL] [Abstract][Full Text] [Related]
7. Medicinal chemistry of adenosine, P2Y and P2X receptors.
Jacobson KA; Müller CE
Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
[TBL] [Abstract][Full Text] [Related]
8. Phosphonate prodrugs: an overview and recent advances.
Heidel KM; Dowd CS
Future Med Chem; 2019 Jul; 11(13):1625-1643. PubMed ID: 31469328
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the synthesis of cyclic 5'-nornucleoside phosphonate analogues.
Shen GH; Hong JH
Carbohydr Res; 2018 Jun; 463():47-106. PubMed ID: 29772449
[TBL] [Abstract][Full Text] [Related]
10. Anti-HIV Nucleoside Phosphonate GS-9148 and Its Prodrug GS-9131: Scale Up of a 2'-F Modified Cyclic Nucleoside Phosphonate and Synthesis of Selected Amidate Prodrugs.
Mackman RL
Curr Protoc Nucleic Acid Chem; 2014 Mar; 56():14.10.1-21. PubMed ID: 25606977
[TBL] [Abstract][Full Text] [Related]
11. An introduction to nucleoside and nucleotide analogues.
Squires KE
Antivir Ther; 2001; 6 Suppl 3():1-14. PubMed ID: 11678469
[TBL] [Abstract][Full Text] [Related]
12. Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities.
Yegutkin GG
Crit Rev Biochem Mol Biol; 2014; 49(6):473-97. PubMed ID: 25418535
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Antiviral Activity Evaluation of 2',5',5'-Trifluoro-Apiosyl Nucleoside Phosphonic Acid Analogs.
Kim E; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2016; 35(3):130-46. PubMed ID: 26855237
[TBL] [Abstract][Full Text] [Related]
14. Membrane Permeable, Bioreversibly Modified Prodrugs of Nucleoside Diphosphate-γ-Phosphonates.
Jia X; Weber S; Schols D; Meier C
J Med Chem; 2020 Oct; 63(20):11990-12007. PubMed ID: 32991174
[TBL] [Abstract][Full Text] [Related]
15. Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases.
Balzarini J; Ford A; Maguire NM; John J; Das K; Arnold E; Dehaen W; Maguire A
Future Med Chem; 2019 Jan; 11(2):137-154. PubMed ID: 30648904
[TBL] [Abstract][Full Text] [Related]
16. Discovery of an acyclic nucleoside phosphonate that inhibits Mycobacterium tuberculosis ThyX based on the binding mode of a 5-alkynyl substrate analogue.
Parchina A; Froeyen M; Margamuljana L; Rozenski J; De Jonghe S; Briers Y; Lavigne R; Herdewijn P; Lescrinier E
ChemMedChem; 2013 Aug; 8(8):1373-83. PubMed ID: 23836539
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral evaluation of alkoxyalkyl esters of acyclic purine and pyrimidine nucleoside phosphonates against HIV-1 in vitro.
Valiaeva N; Beadle JR; Aldern KA; Trahan J; Hostetler KY
Antiviral Res; 2006 Oct; 72(1):10-9. PubMed ID: 16630664
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activities of novel 5-phosphono-pent-2-en-1-yl nucleosides and their alkoxyalkyl phosphonoesters.
Choo H; Beadle JR; Kern ER; Prichard MN; Keith KA; Hartline CB; Trahan J; Aldern KA; Korba BE; Hostetler KY
Antimicrob Agents Chemother; 2007 Feb; 51(2):611-5. PubMed ID: 17130297
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonates.
Prichard MN; Hartline CB; Harden EA; Daily SL; Beadle JR; Valiaeva N; Kern ER; Hostetler KY
Antimicrob Agents Chemother; 2008 Dec; 52(12):4326-30. PubMed ID: 18852272
[TBL] [Abstract][Full Text] [Related]
20. Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.
Jacobson KA; Costanzi S; Ohno M; Joshi BV; Besada P; Xu B; Tchilibon S
Curr Top Med Chem; 2004; 4(8):805-19. PubMed ID: 15078212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
